Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013, Article ID 634929, 7 pages
Review Article

Indirect Comparison Showed Survival Benefit from Adjuvant Chemoradiotherapy in Completely Resected Gastric Cancer with D2 Lymphadenectomy

1Department of Oncology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510120, China
2Department of Oncology, Huizhou Center Hospital, Huizhou 516001, China

Received 2 August 2013; Accepted 29 August 2013

Academic Editor: Qiang Xia

Copyright © 2013 Qiong Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Yaxiong Zhang, Jin Sheng, Shiyang Kang, Wenfeng Fang, Yue Yan, Zhihuang Hu, Shaodong Hong, Xuan Wu, Tao Qin, Wenhua Liang, and Li Zhang, “Patients with Exon 19 Deletion Were Associated with Longer Progression-Free Survival Compared to Those with L858R Mutation after First-Line EGFR-TKIs for Advanced Non-Small Cell Lung Cancer: A Meta-Analysis,” Plos One, vol. 9, no. 9, 2014. View at Publisher · View at Google Scholar
  • Xuanzhang Huang, Peng Gao, Jingxu Sun, Xiaowan Chen, Yongxi Song, Junhua Zhao, Huimian Xu, and Zhenning Wang, “Clinicopathological and prognostic significance of circulating tumor cells in patients with gastric cancer: A meta-analysis,” International Journal of Cancer, 2014. View at Publisher · View at Google Scholar
  • J. W. Liang, Z. C. Zheng, T. Yu, X. Wang, and J. J. Zhang, “Is postoperative adjuvant chemoradiotherapy efficacious and safe for gastric cancer patients with D2 lymphadenectomy? A meta-analysis of the literatur,” Ejso, vol. 40, no. 12, pp. 1614–1621, 2014. View at Publisher · View at Google Scholar
  • Mitsuro Kanda, Yasuhiro Kodera, and Junichi Sakamoto, “Updated evidence on adjuvant treatments for gastric cancer,” Expert Review Of Gastroenterology & Hepatology, vol. 9, no. 12, pp. 1549–1560, 2015. View at Publisher · View at Google Scholar
  • Meng-long Zhou, Mei Kang, Gui-chao Li, Xiao-mao Guo, and Zhen Zhang, “Postoperative chemoradiotherapy versus chemotherapy for R0 resected gastric cancer with D2 lymph node dissection: an up-to-date meta-analysis,” World Journal of Surgical Oncology, vol. 14, no. 1, 2016. View at Publisher · View at Google Scholar
  • Yuanyuan Lei, Siyang Liu, Jinji Yang, Haiyan Tu, Wei Deng, Honghong Yan, and Yilong Wu, “Comparing overall survival between first generation EGFR-TKIs and chemotherapy in lung cancer patients with Del19/L858R,” Chinese Journal of Cancer Research, vol. 28, no. 3, pp. 339–347, 2016. View at Publisher · View at Google Scholar
  • Jia-Qi Wu, Jing Zhai, Chong-Yong Li, Ai-Min Tan, Ping Wei, Li-Zong Shen, and Ming-Fang He, “Patient-derived xenograft in zebrafish embryos: a new platform for translational research in gastric cancer,” Journal of Experimental & Clinical Cancer Research, vol. 36, no. 1, 2017. View at Publisher · View at Google Scholar
  • Zhenyu Zhu, Jie Guan, Xin Liu, Weipeng Gong, Qingsheng Hou, Hongwei Zhao, Shanshan Liu, and Hongliang Guo, “Outcomes of radiation therapy for resectable M0 gastric cancer,” Oncotarget, vol. 9, no. 2, pp. 1726–1734, 2018. View at Publisher · View at Google Scholar